Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7501 AL 7515

Computational Approaches for Multitarget Drug Design in Alzheimer's Disease: A Comprehensive Review

Guerguer FZ, Khedraoui M, Samadi A, Chtita S.

Curr Med Chem. 2025;32(32):7017-7044. doi: 10.2174/0109298673320300240930064551.

The neuroprotective role of volatile oils: insights into chemical profiles, characteristics, neurochemical mechanisms, and preclinical studies in Alzheimer's disease

Suryawanshi M, Gujarathi P, Prajapati B, Vinchurkar K, Gujarathi P.

Inflammopharmacology. 2025 Feb;33(2):627-667. doi: 10.1007/s10787-024-01626-5. Epub 2025 Jan 22.

Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer's disease

Azam U, Naseer MM, Rochais C.

Eur J Med Chem. 2025 Mar 15;286:117277. doi: 10.1016/j.ejmech.2025.117277. Epub 2025 Jan 17.

Transforming Alzheimer's Treatment: Unveiling New Potential with Drug Repurposing Strategies

Mishra AS, Vasanthan M, Ghosh B, Sivakumar PM.

Curr Med Chem. 2025;32(30):6563-6602. doi: 10.2174/0109298673341391241231054936.

Unlocking the Therapeutic Potential of Natural Products for Alzheimer's Disease

Li Z, Zhang Z, Yu B.

J Med Chem. 2025 Feb 13;68(3):2377-2402. doi: 10.1021/acs.jmedchem.4c03049. Epub 2025 Jan 26.

Research Progress in the Molecular Mechanism of NLRP3 Inflammasome in Alzheimer's Disease and Regulation by Natural Plant Products

Zu R, Lu H, Liu W, Shao S, Zheng J, Ying X, Zhou Y, Li Z, Wang W, Li D, Peng Q, Ma H, Zhang Z, Sun Y.

Mol Neurobiol. 2025 Jun;62(6):7296-7312. doi: 10.1007/s12035-025-04715-w. Epub 2025 Jan 28.

Perivascular brain clearance as a therapeutic target in cerebral amyloid angiopathy and Alzheimer's disease

Bonnar O, Eyre B, van Veluw SJ.

Neurotherapeutics. 2025 Apr;22(3):e00535. doi: 10.1016/j.neurot.2025.e00535. Epub 2025 Jan 30.

Microglial polarization in Alzheimer's disease: Mechanisms, implications, and therapeutic opportunities

Yang X, Wang J, Jia X, Yang Y, Fang Y, Ying X, Li H, Zhang M, Wei J, Pan Y.

J Alzheimers Dis. 2025 Mar;104(1):3-13. doi: 10.1177/13872877241313223. Epub 2025 Feb 2.

Regulatory Mechanisms and Therapeutic Implications of Lysosomal Dysfunction in Alzheimer's Disease

Kim Y, Ha TY, Lee MS, Chang KA.

Int J Biol Sci. 2025 Jan 13;21(3):1014-1031. doi: 10.7150/ijbs.103028. eCollection 2025.

Alzheimer's Disease: Exploring Pathophysiological Hypotheses and the Role of Machine Learning in Drug Discovery

Dominguez-Gortaire J, Ruiz A, Porto-Pazos AB, Rodriguez-Yanez S, Cedron F.

Int J Mol Sci. 2025 Jan 24;26(3):1004. doi: 10.3390/ijms26031004.

Reinforcing Nrf2 Signaling: Help in the Alzheimer's Disease Context

la Torre A, Lo Vecchio F, Angelillis VS, Gravina C, D'Onofrio G, Greco A.

Int J Mol Sci. 2025 Jan 28;26(3):1130. doi: 10.3390/ijms26031130.

Microglial NLRP3 Inflammasomes in Alzheimer's Disease Pathogenesis: From Interaction with Autophagy/Mitophagy to Therapeutics

Ayyubova G, Madhu LN.

Mol Neurobiol. 2025 Jun;62(6):7124-7143. doi: 10.1007/s12035-025-04758-z. Epub 2025 Feb 14.

Transcranial electrical stimulation as a therapeutic strategy for Alzheimer's disease: Current uses and challenges

Wang H, Qin N, Maimaitiaili D, Wu J, Wang S, Zhou Y, Lu J, Li Y.

J Alzheimers Dis. 2025 Mar;104(2):297-305. doi: 10.1177/13872877251315777. Epub 2025 Feb 24.

Promising Natural Remedies for Alzheimer's Disease Therapy

Thawabteh AM, Ghanem AW, AbuMadi S, Thaher D, Jaghama W, Karaman D, Karaman R.

Molecules. 2025 Feb 17;30(4):922. doi: 10.3390/molecules30040922.

Unveiling the mTOR pathway modulation by SGLT2 inhibitors: a novel approach to Alzheimer's disease in type 2 diabetes

Ramakrishan P, Rajangam J, Mahinoor SS, Bisht S, Mekala S, Upadhyay DK, Solomon VR, Sabarees G, Pelluri R.

Metab Brain Dis. 2025 Feb 26;40(3):132. doi: 10.1007/s11011-025-01555-4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias